Advertisement
BillionToOne, Inc.

BillionToOne, Inc. (BLLN) Stock Overview

Explore BillionToOne, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BLLNNASDAQ
HealthcareMedical - Diagnostics & Research
$100.04
$5.61(5.94%)
U.S. Market is Open · 14:36
Advertisement

BillionToOne, Inc. (BLLN)

Meyka AI Score

Z

Key Financials

Market Cap4.7B
P/E Ratio185.19
EPS (TTM)$0.53
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$80.67
3 Months$47.78
1 Year Target$31.99

BLLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BillionToOne, Inc. (BLLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $31.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 185.19 and a market capitalization of 4.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
8.43%
5-Day Change
3.07%
1-Month Change
10.14%
3-Month Change
41.99%
6-Month Change
-6.52%
Year-to-Date (YTD) Change
25.11%
1-Year Change
-6.01%
3-Year Change
-6.01%
5-Year Change
-6.01%
All-Time (Max) Change
-6.01%

Contact Information

(650) 460-2551
1035 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

620 Employees
IPO DateNov 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions